Cytomegalovirus Infection in Heart Transplant Recipients Is Associated With Impaired Endothelial Function
- 14 September 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 110 (11_suppl_1), II207-12
- https://doi.org/10.1161/01.cir.0000138393.99310.1c
Abstract
Background— Cardiac allograft vasculopathy (CAV) is initiated by allograft endothelial injury. We hypothesized that a major mechanism by which cytomegalovirus (CMV) could contribute to CAV is by dysregulation of the endothelial vasomotor response. Methods— Coronary endothelial vasomotor function was determined in 183 consecutive patients (24±33 months after transplantation), and was correlated with recipient and donor CMV serological status before transplantation and with documented CMV infection episodes (CMVpp65Ag+). Serial endothelial function measurements were performed in a subgroup of 53 transplant recipients (1 month and 12 months after transplantation). The composite endpoint of cardiovascular related events and death during a follow-up of 66±41 months was analyzed based on the CMV serological status before transplantation. Results— The medium event-free time for CMV-negative recipients of CMV-positive hearts was 8.1 years compared with 13.3 years for the other groups (PPPPPPConclusion— Documented CMV infection episodes in heart transplant recipients are associated with impaired coronary endothelial function. CMV-negative recipients of CMV-positive donor hearts have an impaired distal epicardial endothelial function and an increased incidence of cardiovascular-related events and death during follow-up. CMV infection may contribute to allograft failure by accelerating coronary endothelial dysfunction.This publication has 20 references indexed in Scilit:
- Cytomegalovirus Infection Impairs the Nitric Oxide Synthase PathwayCirculation, 2004
- Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant ???atheroma???Transplantation, 2003
- Diagnostic accuracy of coronary angiography and risk factors for post–heart-transplant cardiac allograft vasculopathyTransplantation, 2003
- Cardiac Allograft Vasculopathy and Dysregulation of the NO Synthase PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- IMPACT OF CYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN ON OUTCOME AFTER CARDIOTHORACIC TRANSPLANTATIONTransplantation, 2001
- Coronary Artery Disease in the Transplanted HeartAnnual Review of Medicine, 2000
- Uninfected and Cytomegalic Endothelial Cells in Blood during Cytomegalovirus Infection: Effect of Acute RejectionThe Journal of Infectious Diseases, 2000
- Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteriesJournal of the American College of Cardiology, 1995
- Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients.Thorax, 1995
- Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infectionThe American Journal of Cardiology, 1989